HALB News and Press, Tykhe Corp From 06/21/21

JACKSON CENTER, PA / ACCESSWIRE / June 21, 2021 / Halberd Corporation's (OTC PINK:HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases); eradicating the antibody-disease combination through radiofrequency waves or laser or other means. Cu...

Enables Extracorporeal Eradication of Pathogens from Cerebral Spinal Fluid Via Radio Frequency and/or Laser Emissive Energy Jackson Center, Pennsylvania--(Newsfile Corp. - June 16, 2021) - Halberd Corporation (OTC Pink: HALB) has successfully conjugated Tau, Phosphorylated Tau and Beta Amyloi...

JACKSON CENTER, PA / ACCESSWIRE / June 9, 2021 / Halberd Corporation (OTC PINK:HALB) commences experimentations to eradicate three of the principal components of Alzheimer's Disease. By eliminating these three critical antigens, which form the basis for neurofibrillary tangles in the brain...

Demonstrates Greater Binding Affinity Than Previous Antibodies JACKSON CENTER, PA / ACCESSWIRE / June 7, 2021 / Halberd Corporation (OTC PINK:HALB) announces the successful creation of two new neutralizing antibodies against the Spike Protein of SARS-CoV-2, both with a stronger bindin...

Jackson Center, Pennsylvania--(Newsfile Corp. - June 1, 2021) - Halberd Corp. (OTC Pink: HALB) announced the filing of a U. S. joint provisional patent application titled, "Antibody Conjugated Nanoparticle Assay And Treatment For SARS-CoV-2." The innovation is a result of Halberd's Sponsore...

Breakthrough Achievement Enables Extracorporeal Eradication of Pathogens Via Radio Frequency Waves and/or Laser Emissive Energy JACKSON CENTER, PA / ACCESSWIRE / May 25, 2021 / Halberd Corporation (OTC PINK:HALB) announces the successful conjugation of gold-coated iron nanoparticles w...

JACKSON CENTER, PA / ACCESSWIRE / May 19, 2021 / Halberd Corporation (OTC PINK:HALB) was featured in a recent MarketWatch article, "New Approaches to Covid-19 Treatment Enter the Picture," along with six other notable biotechnology companies. As stated in the article, "The Covid-19 treat...

JACKSON CENTER, PA / ACCESSWIRE / May 17, 2021 / Halberd Corporation (OTC PINK:HALB) announces the successful conjugation of gold-coated iron nanoparticles with Halberd's patent-pending monoclonal antibody against the SARS-CoV-2 spike protein. This milestone paves the way for testing to pr...

JACKSON CENTER, PA / ACCESSWIRE / May 13, 2021 / Halberd Corporation (OTC PINK:HALB) announces the commencement of its patented extra-corporeal process experimentation using lasers to eradicate disease. This technology facilitates disease eradication without the side-effects normally assoc...

The Covid-19 treatment response process includes a number of different major players, including Pfizer Inc (NYSE:PFE), BioNTech SE – ADR (NASDAQ:BNTX), Moderna Inc (NASDAQ:MRNA), AstraZeneca plc (NASDAQ:AZN), Novavax Inc (NASDAQ:NVAX), Halberd Corp (OTCMKTS:HALB), and Johnson & Joh...